Legal Opinion
Eli Lilly and Co. v. Teva Pharmaceuticals Usa, Inc.
Court of Appeals for the Federal Circuit
Decided September 1, 2010No. 2010-1005, 2010-1033PublishedCited by 17 opinions
1Opinion of the Court
RADER, Chief Judge.
Following an 11-day bench trial, defendant Teva Pharmaceuticals USA, Inc. (“Teva”) appeals the district court’s permanent injunction preventing any manufacture or distribution of a generic version of the drug Evista® until the expiration of U.S. Patent Nos. 6,906,086 (the “'086 patent”); RE39,049 (the “'049 patent”); RE38,968 (the “'968 patent”) (collectively the “Bone Loss Patents”); and RE39,050 (the “'050 patent” or the “Low Dose Patent”). See Eli Lilly & Co. v. Teva Pharms. USA, Inc., 657 F.Supp.2d 967 (S.D.Ind.2009). Plaintiff Eli Lilly & Co. (“Lilly”) cross appeals…
2Cases cited8 opinions
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Richard Ruiz and Foundation Anchoring Systems, Inc., Plaintiffs-Cross v. A.B. Chance CompanyCourt of Appeals for the Federal Circuit · 2000
- Ralston Purina Company v. Far-Mar-Co, Inc.Court of Appeals for the Federal Circuit · 1985
- Georgia-Pacific Corporation, Plaintiff-Cross v. United States Gypsum Company and L&w Supply CorporationCourt of Appeals for the Federal Circuit · 1999
3 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Whitserve, LLC v. Computer Packages, Inc.Court of Appeals for the Federal Circuit · 2012
- Celsis in Vitro, Inc. v. CellzDirect, Inc.Court of Appeals for the Federal Circuit · 2012
- Aventis Pharma S.A. v. Hospira, Inc.Court of Appeals for the Federal Circuit · 2012
- Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
- Mintz v. Dietz & Watson, Inc.Court of Appeals for the Federal Circuit · 2012
12 more not listed; retrieve them via the Exa API.